Exogenous and Endogenous Postprandial Lipid Abnormalities in Type 2 Diabetic Patients with Optimal Blood Glucose Control and Optimal Fasting Triglyceride Levels

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 5, 2004, Pages 2153-2159

  Rivellese, Angela A ^a   De Natale, Claudia ^a   Di Marino, Lucrezia ^a   Patti, Lidia ^a   Iovine, Ciro ^a   Coppola, Silvana ^a   Del Prato, Stefano ^b   Riccardi, Gabriele ^a   Annuzzi, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EVALUATION; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; LIPASE; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 2442428178     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031764     Document Type: Article

References (28)

1. Mero N, Syvanne M, Taskinen MR 1998 Postprandial lipid metabolism in diabetes. Atherosclerosis 141(Suppl 1):S53-S55
2. Taskinen MR 2003 Diabetes dyslipidaemia: from basic research to clinical practice. Diabetologia 46:733-749
3. Chen YD, Swami S, Skowronski R, Coulston A, Reaven GM 1993 Differences in postprandial lipemia between patients with normal glucose tolerance and non insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 76:172-177
4. Syvanne M, Hilden H, Taskinen MR 1994 Abnormal metabolism of postprandial lipoproteins in patients with non insulin-dependent diabetes mellitus is not related to coronary artery disease. J. Lipid Res 35:15-36
5. Curtin A, Degan P, Owens D, Collins P, Johnson A, Tomkin GH 1994 Alterations in apolipoprotein B 48 in the postprandial state in NIDDM. Diabetologia 37:1259-1264
6. Reznik Y, Pousse P, Herrou M, Morello R, Mahoundeau J, Drosdowsky MA, Fradin S 1996 Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism. Metabolism 45:63-71
7. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Getz GS, Polonsky KS 1991 Fasting hypertriglyceridemia in noninsulin dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 72:934-944
8. Kenneth C-W, Cooper AD 2001 Postprandial lipoprotein and atherosclerosis. Front Biosci 6:d332
9. Jeppesen J, Hollenbeck CB, Zhou MY, Coulston A M, Jones C, Chen YDI, Reaven GM 1994 Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity and postprandial lipemia. Arterioscler Thromb. Vasc Biol 1995 15:320-324
10. Goldberg IJ, Kako Y, Lutz EP 2000 Responses to eating: lipoproteins, lipolytic products and atherosclerosis. Curr Opin Lipidol 11:235-241
11. Panarotto D, Remillard P, Bouffard L, Maheux P 2002 Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest 32:84-92
12. WHO 1999 Expert Committee on Diabetes Mellitus. Geneva: WHO
13. Redgrave T, Carlson LA 1979 Change in plasma very low density and low density lipoprotein content, composition and size after a fatty meal in normo- and hypertriglyceridemic men. J Lipid Res 20:217-230
14. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A Metabolism of triglycerides-rich lipoprotein during alimentary lipemia. J Clin Invest 91:748-759
15. Patti L, Romano G, Di Marino L, Annuzzi G, Mancini M, Riccardi G, Rivellese AA 1993 Abnormal distribution of VLDL subfractions in type 1 (insulin-dependent) diabetic patients: could plasma lipase activities play a role? Diabetologia 36:155-160
16. Holmquist L 1982 Surface modification of Beckman Ultra-Clear centrifuge tubes for density gradient ultracentrifugation of lipoprotein. J Lipid Res 23: 1249-1250
17. Lopes-Virella MF, Stone P, Elliss Colwell JA 1997 Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23:882-884
18. Karpe F, Hamsten A 1994 Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res 35:1311-1317
19. Nilsson-Ehle P, Ekman R 1997 Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 3:194-209
20. Harris WS, Lu G, Rambjor GS, Walen AI, Ontko JA, Cheng Q, Windsor SL 1997 Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. Am J Clin Nutr 66:254-60
21. American Diabetes Association 2003 Clinical practice recommendations. Diabetes Care 26(Suppl 1):S83-S86
22. Malmstrom R, Packard CJ, Caslake M, Bedford D, Stawart P, YKI-Jarvinen H, Shepherd J, Taskinen MR 1997 Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40:454-462
23. Zampelas A, Roche H, Knapper JME, Jackson KG, Tomaritis M, Hatzis C, Gibney MJ, Kafatos A, Gould BJ, Wright J, Williams CM 1998 Differences in postprandial lipaemic response between northern and southern Europeans. Atherosclerosis 139:83-93
24. Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin GH 2000 Improved metabolic control reduces the number of postprandial apolipoprotein B-48 containing particles in type 2 diabetes. Atherosclerosis 148:283-291
25. Goldberg IJ 2001 Diabetic Dyslipidemia: causes and consequences. J Clin Endocrinol Metab 86:965-971
26. Ebra T, Conde K, Kako Y, Liu Y, Xu Y, Ramakrishnan R, Goldberg IJ, Shachter NS 2000 Delayed catabolism of apo B-48 lipoproteins due to decreased heparin sulphate proteoglycan production in diabetic mice. J Clin Invest 105:1807-1818
27. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T 1995 Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Atheroeroscler Tromb Vasc Biol 15:1086-1093
28. Eriksson JW, Buren J, Svensson M, Olivecrona T, Olivecrona G 2003 Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects. Atherosclerosis 166:359-367